PCK2 and infection: Although the infection appears non-cytopathic, it was proposed that SARS-CoV-2, including the major gamma, delta, and omicron variants, can stimulate hepatic glucose production and disposal through increased activity of the rate-limiting gluconeogenic enzyme phosphoenolpyruvate carboxykinase (PEPCK)21.